INNOVATION PHARMACEUTICALS INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows, 10 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-12-30: Reporting owner EHRLICH LEO; Form 4; Security Class B Common Stock; Transaction J Other acquisition or disposition (describe transaction).
- 2020-12-28: Reporting owner EHRLICH LEO; Form 4; Security Class B Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-12-28: Reporting owner EHRLICH LEO; Form 4; Security Class B Common Stock; Transaction F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.
- 2020-10-02: Reporting owner EHRLICH LEO; Form 4; Security Class B Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-12-30 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | J Other acquisition or disposition (describe transaction) | −11,307,527 4,333,936 owned after | $0.00 | 2023-01-04 | |
| 2020-12-28 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +13,072,730 17,406,666 owned after | $0.11 | 2022-09-28 | |
| 2020-12-28 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −1,765,203 15,641,463 owned after | $0.21 | 2022-09-28 | |
| 2020-10-02 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +909,090 4,515,032 owned after | $0.11 | 2022-09-28 | |
| 2020-10-02 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −181,096 4,333,936 owned after | $0.22 | 2022-09-28 | |
| 2020-09-08 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,200,000 4,018,180 owned after | $0.11 | 2022-09-28 | |
| 2020-09-08 | EHRLICH LEO Director, Officer (CEO and Chairman) | 4 | Class B Common Stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −412,238 3,605,942 owned after | $0.22 | 2022-09-28 | |
| 2020-03-30 | EHRLICH LEO Director, Officer (CEO and Chairman), 10% Owner | 4 | Class B Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +909,090 1,818,180 owned after | $0.11 | 2020-04-01 | |
| 2019-01-29 | EHRLICH LEO Director, Officer (CEO and Chairman), 10% Owner | 4 | Class B Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +909,090 909,090 owned after | $0.00 | 2019-01-31 | |
| 2010-12-29 | EHRLICH LEO Director, Officer (Chief Executive Officer), 10% Owner | 4 | Common Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000,000 18,000,000 owned after | $0.11 | 2012-07-30 |